Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts
Authors:
- Fred S AppleFAFred S Apple
- the IFCC Committee on Clinical Application of Cardiac Bio-MarkersTBthe IFCC Committee on Clinical Application of Cardiac Bio-Markers
- 5 December 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 67 (1) , 70-78
Abstract
Background: The primary role of the International Federation of Clinical Chemistry (IFCC) Committee on Clinical Application of Cardiac Bio-Markers (C-CB) is to provide educational materials about cardiac biomarker use, emphasizing high-sensitivity cardiac troponin assays. Content: This mini-review, regarding high-sensitivity cardiac and point-of-care troponin assays, addresses 1) new IFCC C-CB/AACC Academy laboratory practice recommendations; 2) new and updated concepts from the Fourth Universal Definition of Myocardial Infarction; 3) the role of point-of-care assays in practice and research; 4) regulatory challenges concerning point-of-care assays; e) testing in the COVID-19 world. Summary: Implementation of high-sensitivity cardiac troponin assays makes a difference now and into the future in clinical practice and research. Providing point-of-care high-sensitivity cardiac troponin assays and optimizing studies to allow clearance of these assays by regulatory agencies, in a timely fashion, may provide improved patient management and outcomes.Keywords
This publication has 32 references indexed in Scilit:
- IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assaysClinical Biochemistry, 2015
- Cost consequences of point-of-care troponin T testing in a Swedish primary health care settingScandinavian Journal of Primary Health Care, 2014
- Improving the 510(k) FDA Process for Cardiac Troponin Assays: In Search of Common GroundClinical Chemistry, 2014
- Three-month outcome of patients with suspected acute coronary syndrome using point-of-care cardiac troponin-T testing compared with laboratory-based cardiac troponin-T testing: a randomised trialEmergency Medicine Journal, 2014
- One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin TArchives of internal medicine (1960), 2012
- Interhospital variation in the RATPAC Trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers)Emergency Medicine Journal, 2011
- The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency departmentHeart, 2010
- Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomised controlled trialEmergency Medicine Journal, 2010
- A Multicenter Randomized Controlled Trial Comparing Central Laboratory and Point-of-Care Cardiac Marker Testing Strategies: The Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) TrialAnnals of Emergency Medicine, 2009
- Impact of Point‐of‐care Testing in the Emergency Department Evaluation and Treatment of Patients with Suspected Acute Coronary SyndromesAcademic Emergency Medicine, 2008